✦ LIBER ✦

1-30-23 Loss of long duration response to levodopa in Parkinson's disease

✍ Scribed by M. Zappia; R. Montesanti; R. Colao; M. Plastino; F. Frangipane; A. Quattrone

Book ID: 119469113
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 346 KB
Volume: 150
Category: Article
ISSN: 0022-510X
DOI: 10.1016/s0022-510x(97)85059-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The long duration response to levodopa i

The long duration response to levodopa in Parkinson's disease

✍ D.L Madden; J.G.L Morris; S.J Graham; M Katekar; D.N Wade 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 718 KB

Long-duration response to levodopa influ

Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease

✍ Mario Zappia; Rosanna Colao; Rita Montesanti; Milena Rizzo; Umberto Aguglia; Ant 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 2 views

The role of the long-duration response t

The role of the long-duration response to levodopa in Parkinson’s disease

✍ Mario Zappia; Alessandra Nicoletti 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 121 KB

The subacute levodopa test for evaluatin

The subacute levodopa test for evaluating long-duration response in parkinson's disease

✍ Prof Aldo Quattrone; Mario Zappia; Umberto Aguglia; Damiano Branca; Rosanna Cola 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Modeling the Short- and Long-Duration Re

Modeling the Short- and Long-Duration Responses to Exogenous Levodopa and to Endogenous Levodopa Production in Parkinson's Disease

✍ Phylinda L. S. Chan; John G. Nutt; Nicholas H. G. Holford 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 292 KB

Cerebral atrophy and long-term response

Cerebral atrophy and long-term response to levodopa in Parkinson's disease

✍ E. Schneider; P.-A. Fischer; P. Jacobi; H. Becker; M. Beyer 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 437 KB

In 92 parkinsonian patients (42 men, 50 women) aged from 37-79 years (mean 62.8) the impact of cerebral atrophy as assessed by computed tomography on the course of the clinical symptomatology under levodopa during a period of 1 to 5 years was investigated. It could be shown that patients suffering f